The activities of this Core will provide services to all projects in the characterization of behavioral phenotypes/endophenotypes of mice under study as models for the molecular genetics of schizophrenia. This core will utilize the Neurogenetics and Behavior Center (NBC), a unique resource contributing to NIH supported research programs using mouse models and gene targeting technology to study basic functions of the brain and disorders relevant to psychiatric and neurological disease. As such, the behavioral studies in the facility are integral to bridging from genomic/molecular/cellular levels of analysis to the study of behavioral systems and functional disorders. In its past 4 years of operation, NBC has established and optimized over 80 protocols for behavioral assessments in 3 primary domains: cognitive functions, affective motivational processes, and sensorimotor integration. We draw on this repertoire of behavioral technology in the Core plan. Initial screening of mice in the research program overall will be conducted within the phenotyping facilities at the Broadway Research Building (BRB) where the mice will be generated and housed for use in Projects 1-3. These protocols will include 1) a basic battery for neurological assessment, 2) activity assessments including tests in environments that yield generalized affective measures (e.g. plus maze), 3) a well-characterized assessment for sensorimotor gating (pre-pulse inhibition). Additional test mice will be generated within the BRB facilities for extensive behavioral analysis in the NBC facilities;these test subjects will be transferred at appropriate ages in numbers required for the experimental design of studies described herein. The proposed behavioral assessments at NBC are chosen to target the neurodevelopmental trajectory of disease and directed to key neural circuitry that appears most affected in this disorder. Thus we focus on specific behavioral protocols to assess limbic and cortical (particularly prefrontal) circuits. A cross-cutting behavioral platform to identify endophenotypes in these mouse models will include context and trace conditioning (hippocampal system), latent inhibition (hippocampal and forebrain dopamine systems), reversal learning and reinforcer devaluation (prefrontal function) and working memory/recognition memory assessments (temporal lobe and prefrontal circuits). A particular advantage of testing in the Core resource is not only to serve the specific objectives of the individual projects within this research program but to acquire datasets using common behavioral protocols across models of neuropsychiatric disease. Through the datasharing provisions of the NBC, once published, the results of this research will be accessible to the broad scientific community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Exploratory Grants (P20)
Project #
5P20MH084018-03
Application #
8080401
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2010-06-01
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
3
Fiscal Year
2010
Total Cost
$88,688
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Sumitomo, Akiko; Yukitake, Hiroshi; Hirai, Kazuko et al. (2018) Ulk2 controls cortical excitatory-inhibitory balance via autophagic regulation of p62 and GABAA receptor trafficking in pyramidal neurons. Hum Mol Genet 27:3165-3176
Posporelis, Sotirios; Coughlin, Jennifer M; Marsman, Anouk et al. (2018) Decoupling of Brain Temperature and Glutamate in Recent Onset of Schizophrenia: A 7T Proton Magnetic Resonance Spectroscopy Study. Biol Psychiatry Cogn Neurosci Neuroimaging 3:248-254
Sagata, Noriaki; Kato, Takahiro A; Kano, Shin-Ichi et al. (2017) Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study. Sci Rep 7:13905
Nucifora, L G; Tanaka, T; Hayes, L N et al. (2017) Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry 7:e1215
Pandey, Himani; Bourahmoune, Katia; Honda, Takato et al. (2017) Genetic interaction of DISC1 and Neurexin in the development of fruit fly glutamatergic synapses. NPJ Schizophr 3:39
Lavoie, Joëlle; Sawa, Akira; Ishizuka, Koko (2017) Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research. Curr Opin Psychiatry 30:176-183
Lavoie, Joëlle; Gassó Astorga, Patricia; Segal-Gavish, Hadar et al. (2017) The Olfactory Neural Epithelium As a Tool in Neuroscience. Trends Mol Med 23:100-103
Tanaka, Motomasa; Ishizuka, Koko; Nekooki-Machida, Yoko et al. (2017) Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington's disease. J Clin Invest 127:1438-1450
Shao, Lisha; Lu, Binyan; Wen, Zhexing et al. (2017) Disrupted-in-Schizophrenia-1 (DISC1) protein disturbs neural function in multiple disease-risk pathways. Hum Mol Genet 26:2634-2648
Niwa, M; Cash-Padgett, T; Kubo, K-I et al. (2016) DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1. Mol Psychiatry 21:1488-1489

Showing the most recent 10 out of 112 publications